Genomic Grade Index predicts postoperative clinical outcome of GIST.

Item

http://www.wikidata.org/entity/Q36387916

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Genomic Grade Index predicts postoperative clinical outcome of GIST.

@ast

Genomic Grade Index predicts postoperative clinical outcome of GIST.

@en

type

Item

label

Genomic Grade Index predicts postoperative clinical outcome of GIST.

@ast

Genomic Grade Index predicts postoperative clinical outcome of GIST.

@en

prefLabel

Genomic Grade Index predicts postoperative clinical outcome of GIST.

@ast

Genomic Grade Index predicts postoperative clinical outcome of GIST.

@en

P1476

Genomic Grade Index predicts postoperative clinical outcome of GIST.

@en

P2093

D Birnbaum

http://www.w3.org/2001/XMLSchema#string

F Bertucci

http://www.w3.org/2001/XMLSchema#string

H Kim

http://www.w3.org/2001/XMLSchema#string

J Ostrowski

http://www.w3.org/2001/XMLSchema#string

M A Pantaleo

http://www.w3.org/2001/XMLSchema#string

M Polkowski

http://www.w3.org/2001/XMLSchema#string

P Finetti

http://www.w3.org/2001/XMLSchema#string

W K Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

Molecular targets for tumour progression in gastrointestinal stromal tumours.

Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression.

Cyclin H expression is increased in GIST with very-high risk of malignancy

Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.

Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors.

P2888

bjc.2012.390

P304

1433-1441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2012.390

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Annalisa Astolfi

P577

2012-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230755958

http://www.w3.org/2001/XMLSchema#string

P6179

1026371552

http://www.w3.org/2001/XMLSchema#string

P698

22929880

http://www.w3.org/2001/XMLSchema#string

P932

3494448

http://www.w3.org/2001/XMLSchema#string